Technical Note – Approaches to chiral products: Racemic resolution

by Galchimia

​The importance of enantiomeric purity in pharmaceutical products is widely known, something humanity learnt the hard way. Unfortunately, obtaining enantiopure compounds can sometimes be very expens...

Read more

GalChimia, reconocida con el Sello de PYME Innovadora

by Galchimia

​El Ministerio de Ciencia e Innovación de España (MICINN) ha concedido a GalChimia el Sello de PYME Innovadora.

Read more

Resultados del proyecto IO4COLON

by Galchimia

Investigación industrial para el descubrimiento de nuevos fármacos inmunoterapéuticos en tratamiento de cáncer de colon

Read more

Synthesisi of Pyrazoles from Acetophenones in Flow

by Galchimia

Flow Chemistry is a key enabling technology that has proven to be particularly advantageous for certain syntheses. Its inherent characteristics offer a wide range of benefits: reactions cannot only be...

Read more

EST64454: A Highly Soluble σ1 Receptor Antagonist Clinical Candidate for Pain Management

by Galchimia

Our latest article has just been published in the Journal of Medicinal Chemistry, describing some of the work carried out as part of our long-standing collaboration with Esteve ​Pharmaceuticals. The...

Read more

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

by Galchimia

We are happy to share our latest report from the work carried out in collaboration with GlaxoSmithKline and the Drug Discovery Unit of the University of Dundee. The paper published in RSC Medicinal Ch...

Read more

GalChimia, empresa colaboradora en el Máster Interuniversitario de Química Orgánica

by Galchimia

Participamos un año más como empresa colaboradora en el Máster de Química Orgánica que imparten conjuntamente la Universidad Autónoma de Madrid (UAM), la Universidad Complutense de Madrid (UCM) ...

Read more

GalChimia in the Spanish Biotech market – 2019 Highlights

by Galchimia

According to the ASEBIO 2019 repo​rt, Spain remains a powerful region in terms of biotechnology and Research & Development efforts. The country counts with nearly 3000 companies working on biotechno...

Read more

Our values: Innovation

by Galchimia

Our business lines are directly and necessarily linked to innovation, since our activity is based on offering research services to industries that are constantly evolving, as are the pharmaceutical ...

Read more

GalChimia renews the accreditation for Crédit d’Impôt Recherche (CIR)

by Galchimia

We are glad to announce that the French Government has renewed GalChimia’s accreditation for C​rédit d’Impôt Recherche (CIR) for three additional years (2020, 2021, 2022). GalChimia provides R...

Read more

Galchimia: Nuestros valores

by Galchimia

La filosofía de GalChimia está definida por cinco valores: Comunicación, Compromiso, Transparencia, Innovación y Orientación al Cliente. Nos sentimos orgullosos de contar con una identidad sólid...

Read more

The state of organic synthesis

by Galchimia

A couple of weeks ago, a colleague sent me a link with a note: «In case it inspires you…». The article in question had a provocative title: Chemists complete synthesis of mole​cule ‘at the lim...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

CNIC scientists identify the key cell ty...

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

It has been examined whether atherosclerosis can be avoided in HGPSrev...

Photos Stream